Bar*** MD

President and CEO

学歴

Yale University

Yale University (1982 - 1985)

  • Degree: Unknown Degree
  • Field of Study: Resident in Internal Medicine
  • Description:

University of Washington School of Medicine (1978 - 1982)

  • Degree: Doctor of Medicine (M.D.)
  • Field of Study: Medicine
  • Description:

University of Washington (1974 - 1978)

  • Degree: Bachelor's Degree
  • Field of Study: Chemistry
  • Description:

スキル:

Clinical Development, Oncology, Biotechnology, Drug Development

職務経験:

President and CEO at Tango Therapeutics

  • Location: Cambridge, MA
  • Duration: 2017-09 to Present
  • Description: Tango Therapeutics is a biotechnology company developing novel medicines for patients by discovering and drugging context-dependent vulnerabilities in cancers. Tango was launched in 2017 by Third Rock Ventures and is headquartered in Cambridge, Mass. For more information, please visit www.tangotx.com.

Board Member at FogPharma

  • Location: Cambridge, Massachusetts
  • Duration: 2018-10 to Present
  • Description:

Board Member at REVOLUTION Medicines

  • Location: Redwood City, California
  • Duration: 2018-04 to Present
  • Description:

Venture Partner at Third Rock Ventures

  • Location: Boston, MA
  • Duration: 2015 to Present
  • Description: Third Rock Ventures is a leading healthcare venture firm focused on disruptive areas of science and medicine to discover, launch and build companies that make a dramatic difference in people’s lives. By combining our team’s scientific vision, strategic leadership, operational expertise and innovative deal-making capabilities, we nurture bold ideas that translate into successful business enterprises. Recognizing that the best way to create value for our investors is to create value for patients, our companies are built on a solid foundation of science, medicine, people and business strategy. For more information, please visit www.thirdrockventures.com.

SVP, Oncology Translational Medicine at Novartis

  • Location: Cambridge, MA
  • Duration: 2009 to 2015
  • Description:
AI履歴書分析

候補者インテリジェンスレポート

米国の採用ディレクターの視点からAI分析 — キャリアの継続性、成長軌道、および役職適合性を評価します。

キャリアの継続性とリスク評価

Employment GapLow

No significant employment gaps; continuous involvement in pharma/biotech leadership and advisory roles from 2009 to present.

Industry ConsistencyLow

Consistent focus on oncology, cancer genetics, translational medicine, and biotech company-building across pharma, venture, and startups.

Tenure StabilityLow

Demonstrates sustained leadership across roles and long tenure at Novartis (2009-2015) with ongoing, multi-year commitments at Tango, Third Rock, and boards; low volatility in career trajectory.

Education-Career MatchLow

MD from Yale with oncology specialization aligns directly with translational medicine, oncology leadership, and drug development responsibilities.

キャリア成長カーブ

SVP, Oncology Translational Medicine Entry
Novartis
2009-2015
Interim Chief Medical Officer Lateral
Neon Therapeutics
2015-2017
Venture Partner Lateral
Third Rock Ventures
2015-Present
Interim Chief Executive Officer Lateral
Tango Therapeutics
2015-2017
President & Chief Executive Officer ↑ 昇進
Tango Therapeutics
2017-Present
Board Member Lateral
Revolution Medicines
2018-Present
Board Member Lateral
FogPharma
2018-Present
評価:Barbara Weber’s career shows a clear upward arc from senior translational medicine leadership at a top pharma to founder-level leadership and governance in venture-backed oncology startups. With long-tenured roles, CEO experience, and ongoing board involvement, she is well-positioned for advanced CEO roles, chief development leadership, or senior operating partner opportunities in biopharma and life sciences investing.

最適な役職(トップ5)

1

Chief Executive Officer (CEO)97% 適合

Proven founder/CEO track record in oncology biotech; strong leadership, fundraising, and strategic execution; aligns with Tango’s success and Barbara’s venture-building experience.

2

Chief Medical Officer (CMO) / Head of Translational Medicine89% 適合

Extensive translational medicine and clinical development background, including interim CMO experience and senior pharma leadership.

3

Chief Development Officer (CDO) – Oncology86% 適合

Bridging clinical development and early discovery programs; proven ability to lead drug development pipelines.

4

Chief Scientific Officer (CSO) / Head of Discovery84% 適合

Strong scientific leadership in oncology genetics and discovery platforms; aligns with Tango’s target discovery capabilities.

5

Operating Partner / Managing Director, Life Sciences VC80% 適合

Proven venture background and board governance; capable of guiding portfolio companies from strategic and operational perspectives.

AI Recruiterを体験する

無料で始めましょう。ライバルに先を越されないでください。

AI駆動の採用ソリューションを活用して、採用プロセスを自動化し、時間コストの80%を削減している10,000社以上の企業に加わりましょう。

33%オフ、残り48時間のみ!
AIを無料で試す

24時間365日自動運用

AIを活用した候補者スクリーニング

地理的・時差の制限なく採用活動

パーソナライズされたインテリジェントコミュニケーション

候補者エンゲージメントの自動評価

あなたの採用スタイルをインテリジェントに模倣・再現

4ヶ月間の返金保証

LinkedInアカウントのセキュリティを確保